Literature DB >> 7714213

Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

I W Fong1, C B Britton, K E Luinstra, E Toma, J B Mahony.   

Abstract

JC virus DNA was detected by PCR in the cerebrospinal fluid of 17 of 23 (73.9%) patients with confirmed cases of progressive multifocal leukoencephalopathy and 2 of 48 (4.2%) controls without progressive multifocal leukoencephalopathy. The sensitivity and specificity of this PCR were 74 and 95.8%, respectively, while the positive and negative predictive values were 89.5 and 88.5%, respectively.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7714213      PMCID： PMC227972          DOI： 10.1128/jcm.33.2.484-486.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Diagnosis of progressive multifocal leucoencephalopathy by PCR detection of JC virus from CSF.

Authors:  P Brouqui; C Bollet; J Delmont; A Bourgeade
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

2.  Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Authors:  J Henson; M Rosenblum; D Armstrong; H Furneaux
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

3.  MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. Pathological correlations.

Authors:  P M Trotot; R Vazeux; H K Yamashita; C Sandoz-Tronca; J Mikol; C Vedrenne; J B Thiébaut; F Gray; M Cikurel; G Pialoux
Journal:  J Neuroradiol       Date:  1990       Impact factor: 3.447

4.  Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.

Authors:  R R Arthur; S Dagostin; K V Shah
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction.

Authors:  T Weber; R W Turner; S Frye; B Ruf; J Haas; E Schielke; H D Pohle; W Lüke; W Lüer; K Felgenhauer
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

6.  Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data.

Authors:  R C Holman; R S Janssen; J W Buehler; M T Zelasky; W C Hooper
Journal:  Neurology       Date:  1991-11       Impact factor: 9.910

Review 7.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

8.  Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.

Authors:  C Tornatore; J R Berger; S A Houff; B Curfman; K Meyers; D Winfield; E O Major
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

9.  Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy.

Authors:  A Telenti; W F Marshall; A J Aksamit; J D Smilack; T F Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

10.  Subclinical central nervous system infection with JC virus in patients with AIDS.

Authors:  E B Quinlivan; M Norris; T W Bouldin; K Suzuki; R Meeker; M S Smith; C Hall; S Kenney
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226
View more
  24 in total

Review 1.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

2.  Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Authors:  E Iacobaeus; C Ryschkewitsch; M Gravell; M Khademi; E Wallstrom; T Olsson; L Brundin; Eo Major
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

3.  Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy.

Authors:  A de Luca; A Cingolani; A Linzalone; A Ammassari; R Murri; M L Giancola; G Maiuro; A Antinori
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

Review 4.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

Review 5.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.

Authors:  Elizabeth C Neil; Lisa M DeAngelis
Journal:  Blood Adv       Date:  2017-10-18

7.  Progressive multifocal leukoencephalopathy in a patient with glioblastoma.

Authors:  Jing Wu; Lauren A Langford; Dawid Schellingerhout; Nandita Guha-Thakurta; Sudhakar Tummala; Jeffrey S Weinberg; Vinay K Puduvalli
Journal:  J Neurooncol       Date:  2010-12-01       Impact factor: 4.130

Review 8.  Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.

Authors:  Valentina Felli; Alessandra Di Sibio; Monica Anselmi; Antonio Gennarelli; Patrizia Sucapane; Alessandra Splendiani; Alessia Catalucci; Carmine Marini; Massimo Gallucci
Journal:  Neuroradiol J       Date:  2014-12-01

Review 9.  Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.

Authors:  Hiroki Yokoyama; Takashi Watanabe; Dai Maruyama; Sung-Won Kim; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2008-10-15       Impact factor: 2.490

10.  JCV detection in multiple sclerosis patients treated with natalizumab.

Authors:  Saud A Sadiq; Lauren M Puccio; Edward W A Brydon
Journal:  J Neurol       Date:  2010-01-07       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.